Endo Pharmaceuticals
-

Blackstone Life Sciences Commits Up To $300 Million to Malvern-Based Uniquity Bio
Malvern-based Uniquity Bio is emerging from stealth mode after getting up to $300 million from Massachusetts-based private equity firm Blackstone Life Sciences, writes John George…
-

2022 VISTA Millennial Superstars: Greg Thomas
Downingtown native Greg Thomas is the Senior Director of Men’s Health Marketing and Chief of Staff for the Global Commercial Operations Leadership Team at Endo…
-

Wall Street Journal: Swamped by Thousands of Opioid-Related Lawsuits, Malvern’s Endo Hires Restructurer
Endo International — based in Dublin, Ireland, with a U.S. headquarters in Malvern — has hired a financial restructuring firm to navigate its current legal…
-

Malvern’s Endo to Acquire Local Company for $658 Million and Bring Its Cellulite-Fighting Drug to Market
Malvern-based Endo Pharmaceuticals has agreed to acquire BioSpecifics Technologies, a 20-year-old company based in Wilmington, for around $658 million, writes Joseph DiStefano for The Philadelphia…
-

Malvern’s Endo Teams Up with John Elway to Spread Awareness of Hand Condition
Malvern-based Endo Pharmaceuticals is joining forces with Hall of Fame quarterback John Elway to raise awareness of a little-known hand condition, writes John George for…
-

Equus Capital Partners Buys Malvern Office Complex, ‘the Front Door to Great Valley’
Equus Capital Partners has purchased an office complex in Malvern for $70 million, writes Natalie Kostelni for the Philadelphia Business Journal. The 300,000-square-foot complex at…
-

Chester County Briefly: January 17
Exton Region Chamber of Commerce Citing a long and distinguished career of outreach, the Exton Region Chamber of Commerce recently bestowed the 2017 Senator Robert…
-

FDA Asks Malvern’s Endo to Pull Opioid Pain Med from Shelves
The rampant drug abuse linked to a Malvern-based opioid pain medication has led to the U.S. Food and Drug Administration’s first-ever call to pull it…
-

Endo Bids To Purchase North Carolina Pharmaceutical Firm
Endo Pharmaceuticals of Malvern has offered to acquire the specialty pharmaceutical firm Salix of Raleigh, N.C. for $175 per share, or $11.2 billion, Philadelphia Business…
-

Auxilium Tells Endo Its Not Ready To Be Acquired, Yet
Auxilium Pharmaceuticals of Chesterbrook says its merger with Canadian biotechnology firm QLT stands firm and it is rejecting Endo International’s proposal to acquire all of…
-

Endo Sells A Slice Of Its Future To Former VP
After leaving Endo Pharmaceuticals to lead a new research and development company, the former senior vice president of discovery and early development for the Malvern-based…
-

Chicago Claims Chester County Firms Are Addicted to Profit
The city of Chicago is blaming a recent epidemic in painkiller drug abuse on two Chester County companies and a host of other drug makers.…
-

Regulatory Infraction Costs Malvern Pharmaceutical Firm $193 Million
While Malvern based Endo Pharmaceuticals, Inc. has been successful marketing branded products to help people live healthier lives, its marketing practices – which stepped outside…













































